Structure based virtual screening of MDPI database: Discovery of structurally diverse and novel DPP-IV inhibitors
- 1 August 2014
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 24 (15), 3447-3451
- https://doi.org/10.1016/j.bmcl.2014.05.076
Abstract
No abstract availableKeywords
Funding Information
- DST (SERC/LS-295/2011)
- DBT
This publication has 48 references indexed in Scilit:
- EFFECT OF THE DIPEPTIDYL PEPTIDASE-4 INHIBITOR SITAGLIPTIN IN OLDER ADULTS WITH TYPE 2 DIABETES MELLITUSJournal of the American Geriatrics Society, 2011
- Diabetes medications and body weightExpert Opinion on Drug Safety, 2009
- Effects of Dipeptidyl Peptidase-4 Inhibition on Gastrointestinal Function, Meal Appearance, and Glucose Metabolism in Type 2 DiabetesDiabetes, 2007
- Bodyweight Changes Associated with Antihyperglycaemic Agents in Type 2 Diabetes MellitusDrug Safety, 2007
- Incretins, insulin secretion and Type 2 diabetes mellitusDiabetologia, 2004
- Development of Glucagon-Like Peptide-1-Based Pharmaceuticals as Therapeutic Agents for the Treatment of DiabetesCurrent Pharmaceutical Design, 2001
- Comparative Tolerability Profiles of Oral Antidiabetic AgentsDrug Safety, 1994
- Dipeptidyl‐peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon‐like peptide‐1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serumJBIC Journal of Biological Inorganic Chemistry, 1993
- Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitusThe American Journal of Cardiology, 1987
- Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham StudyDiabetes Care, 1979